Wangjue Xu
Overview
Explore the profile of Wangjue Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu S, Guo A, Hu H, Ying X, Li Y, Huang Z, et al.
Transl Lung Cancer Res
. 2024 Jul;
13(6):1296-1306.
PMID: 38973965
Background: Driver genes are essential predictors of targeted therapeutic efficacy. Detecting driver gene mutations in lung adenocarcinoma (LUAD) patients can help to screen for targeted drugs and improve patient survival...
2.
Zhu X, Feng X, Huang Z, Xu W, Guo A, Xu J, et al.
J Thorac Dis
. 2024 Jun;
16(5):3291-3305.
PMID: 38883668
Background: Chylothorax is a seldom encountered complication following lung surgery. However, due to the widespread practice of lung surgery, postoperative complications have inevitably arisen. Chylothorax significantly affects a patient's discharge...
3.
Tong F, Lu G, Zang J, Hao D, Xu W, Chen J, et al.
J Int Med Res
. 2023 Nov;
51(11):3000605231211771.
PMID: 37987640
Objective: To investigate the relationship between FKBP prolyl isomerase 5 () gene expression and CD8 T cells in tumour progression and immunology of the luminal B subtype of breast cancer...
4.
Wang Y, Huang S, Feng X, Xu W, Luo R, Zhu Z, et al.
Front Oncol
. 2023 Jun;
13:1145128.
PMID: 37265800
The use of immune checkpoint inhibitors (ICIs) has become mainstream in the treatment of non-small cell lung cancer (NSCLC). The idea of harnessing the immune system to fight cancer is...